Identification of a homozygous BBS7 frameshift mutation in two (related) Chinese Miao families with Bardet-Biedl Syndrome



Posted: 2019-03-07 20:00:00
Background: Bardet-Biedl Syndrome (BBS) is a genetically heterogeneous autosomal recessive disorder with a wide spectrum of clinical features. To date, mutations in 21 different genes (BBS1-21) have been identified as causing isolated or complex BBS phenotypes. In this report, we present three Chinese Miao ethnic patients who were diagnosed with BBS on the basis of characteristic clinical features and investigated the exsome of these patients. Methods: To evaluate disease genes, the Agilent SureSelect system and Illumina HiSeq 2000 platform for whole exome enrichment and sequencing (WES) were used on the proband and her mother. Variants that fit a recessive model of inheritance only were compared and filtered using public databases. Variants detected by exome sequencing were validated by Sanger sequencing. A total of 981 phenotypically normal subjects were enrolled as control data set. Results: A frameshift homozygous germline mutation in BBS7 was detected by WES and identified by Sanger sequencing in affected individuals. This mutation was predicted to result in premature termination of exon5 (c.389_390delAC, p.Asn130ThrfsX3; RefSeq NM_176824.2) and lead to a 133 amino acid truncated protein. The inheritance patterns in the families are consistent with autosomal recessive inheritance, and no such homozygous mutation was found in the other 981 controls. Conclusion: This mutation has not yet been described in any reported literature, and this is the first report on BBS7 mutation in Chinese Miao families with BBS phenotypes.

参考サイト PubMed: exsome


Powered by Stromvergleich


バイオクイックニュース日本語版:エクソソーム特集

バイオクイックニュース日本語版
12月 17, 2019 バイオアソシエイツ

エクソソームが重度の前立腺癌促進伝達因子の送達をしていることが判明。 エクソソーム放出阻害が治療に有用であることが証明された。

ニューロン機能を支援する転写因子は、すでに再発した癌をさらに致命的にする可能性のある前立腺の細胞変換を可能にするようだ。 転写因子BRN4は主に中枢神経系と内耳で発現するが、稀であるが神経内分泌前立腺癌の患者でも増幅され過剰発現する最初の証拠がClinical Cancer Researchジャーナルで公開された。 この論文は「BRN4は去勢抵抗性前立腺癌における神経内分泌分化の新規ドライバーであり、BRN2を含む細胞外小胞で選択的に放出される(BRN4 Is a Novel Driver of…

ゲスト 777人 と メンバー0人 がオンラインです